BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 30528730)

  • 1. Phosphodiesterase 4B is an effective therapeutic target in colorectal cancer.
    Kim DU; Kwak B; Kim SW
    Biochem Biophys Res Commun; 2019 Jan; 508(3):825-831. PubMed ID: 30528730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phosphodiesterase 4B-dependent interplay between tumor cells and the microenvironment regulates angiogenesis in B-cell lymphoma.
    Suhasini AN; Wang L; Holder KN; Lin AP; Bhatnagar H; Kim SW; Moritz AW; Aguiar RCT
    Leukemia; 2016 Mar; 30(3):617-626. PubMed ID: 26503641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The phosphodiesterase PDE4B limits cAMP-associated PI3K/AKT-dependent apoptosis in diffuse large B-cell lymphoma.
    Smith PG; Wang F; Wilkinson KN; Savage KJ; Klein U; Neuberg DS; Bollag G; Shipp MA; Aguiar RC
    Blood; 2005 Jan; 105(1):308-16. PubMed ID: 15331441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene set enrichment analysis unveils the mechanism for the phosphodiesterase 4B control of glucocorticoid response in B-cell lymphoma.
    Kim SW; Rai D; Aguiar RC
    Clin Cancer Res; 2011 Nov; 17(21):6723-32. PubMed ID: 21742807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-124 regulates glucocorticoid sensitivity by targeting phosphodiesterase 4B in diffuse large B cell lymphoma.
    Kim J; Jeong D; Nam J; Aung TN; Gim JA; Park KU; Kim SW
    Gene; 2015 Mar; 558(1):173-80. PubMed ID: 25576220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of phosphodiesterase-4 (PDE4) activity triggers luminal apoptosis and AKT dephosphorylation in a 3-D colonic-crypt model.
    Tsunoda T; Ota T; Fujimoto T; Doi K; Tanaka Y; Yoshida Y; Ogawa M; Matsuzaki H; Hamabashiri M; Tyson DR; Kuroki M; Miyamoto S; Shirasawa S
    Mol Cancer; 2012 Jul; 11():46. PubMed ID: 22830422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disruption of the Myc-PDE4B regulatory circuitry impairs B-cell lymphoma survival.
    Nam J; Kim DU; Kim E; Kwak B; Ko MJ; Oh AY; Park BJ; Kim YW; Kim A; Sun H; Jung Y; Lee JH; Shin HJ; Park I; Song DK; Jeong JY; Lee YH; Kim SW
    Leukemia; 2019 Dec; 33(12):2912-2923. PubMed ID: 31138843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rational combined targeting of phosphodiesterase 4B and SYK in DLBCL.
    Kim SW; Rai D; McKeller MR; Aguiar RC
    Blood; 2009 Jun; 113(24):6153-60. PubMed ID: 19369227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of phosphodiesterase 4D decreases the malignant properties of DLD-1 colorectal cancer cells by repressing the AKT/mTOR/Myc signaling pathway.
    Kim DU; Nam J; Cha MD; Kim SW
    Oncol Lett; 2019 Mar; 17(3):3589-3598. PubMed ID: 30867802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphodiesterase 4B negatively regulates endotoxin-activated interleukin-1 receptor antagonist responses in macrophages.
    Yang JX; Hsieh KC; Chen YL; Lee CK; Conti M; Chuang TH; Wu CP; Jin SC
    Sci Rep; 2017 Apr; 7():46165. PubMed ID: 28383060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AMPK antagonizes hepatic glucagon-stimulated cyclic AMP signalling via phosphorylation-induced activation of cyclic nucleotide phosphodiesterase 4B.
    Johanns M; Lai YC; Hsu MF; Jacobs R; Vertommen D; Van Sande J; Dumont JE; Woods A; Carling D; Hue L; Viollet B; Foretz M; Rider MH
    Nat Commun; 2016 Mar; 7():10856. PubMed ID: 26952277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphodiesterase 4b expression plays a major role in alcohol-induced neuro-inflammation.
    Avila DV; Myers SA; Zhang J; Kharebava G; McClain CJ; Kim HY; Whittemore SR; Gobejishvili L; Barve S
    Neuropharmacology; 2017 Oct; 125():376-385. PubMed ID: 28807677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysregulation of hepatic cAMP levels via altered Pde4b expression plays a critical role in alcohol-induced steatosis.
    Avila DV; Barker DF; Zhang J; McClain CJ; Barve S; Gobejishvili L
    J Pathol; 2016 Sep; 240(1):96-107. PubMed ID: 27287961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclic-AMP signalling, MYC and hypoxia-inducible factor 1α intersect to regulate angiogenesis in B-cell lymphoma.
    Ethiraj P; Sasi B; Holder KN; Lin AP; Qiu Z; Jaafar C; Elkhalili A; Desai P; Saksena A; Ritter JP; Aguiar RCT
    Br J Haematol; 2022 Jul; 198(2):349-359. PubMed ID: 35411936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-immunosuppressive triazole-based small molecule induces anticancer activity against human hormone-refractory prostate cancers: the role in inhibition of PI3K/AKT/mTOR and c-Myc signaling pathways.
    Leu WJ; Swain ShP; Chan SH; Hsu JL; Liu SP; Chan ML; Yu CC; Hsu LC; Chou YL; Chang WL; Hou DR; Guh JH
    Oncotarget; 2016 Nov; 7(47):76995-77009. PubMed ID: 27769069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of PDE4/PDE4B improves renal function and ameliorates inflammation in cisplatin-induced acute kidney injury.
    Xu M; Yu X; Meng X; Huang S; Zhang Y; Zhang A; Jia Z
    Am J Physiol Renal Physiol; 2020 Mar; 318(3):F576-F588. PubMed ID: 31961716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of phosphodiesterase 4B (PDE4B) activates protein kinase A and contributes to the progression of prostate cancer.
    Kashiwagi E; Shiota M; Yokomizo A; Itsumi M; Inokuchi J; Uchiumi T; Naito S
    Prostate; 2012 May; 72(7):741-51. PubMed ID: 22529021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for reprogramming of monocytes into reparative alveolar macrophages in vivo by targeting PDE4b.
    Rochford I; Joshi JC; Rayees S; Anwar M; Akhter MZ; Yalagala L; Banerjee S; Mehta D
    Am J Physiol Lung Cell Mol Physiol; 2021 Oct; 321(4):L686-L702. PubMed ID: 34318714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ferulic acid prevents LPS-induced up-regulation of PDE4B and stimulates the cAMP/CREB signaling pathway in PC12 cells.
    Huang H; Hong Q; Tan HL; Xiao CR; Gao Y
    Acta Pharmacol Sin; 2016 Dec; 37(12):1543-1554. PubMed ID: 27665850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenge of human Jurkat T-cells with the adenylate cyclase activator forskolin elicits major changes in cAMP phosphodiesterase (PDE) expression by up-regulating PDE3 and inducing PDE4D1 and PDE4D2 splice variants as well as down-regulating a novel PDE4A splice variant.
    Erdogan S; Houslay MD
    Biochem J; 1997 Jan; 321 ( Pt 1)(Pt 1):165-75. PubMed ID: 9003416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.